How I prescribe prolonged intermittent renal replacement therapy

被引:6
|
作者
Clark, Edward G. [1 ]
Vijayan, Anitha [2 ]
机构
[1] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada
[2] Washington Univ, Div Nephrol, St Louis, MO USA
关键词
CRITICALLY-ILL PATIENTS; INTENSITY; DIALYSIS; FAILURE;
D O I
10.1186/s13054-023-04389-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Prolonged Intermittent Renal Replacement Therapy (PIRRT) is the term used to define 'hybrid' forms of renal replacement therapy. PIRRT can be provided using an intermittent hemodialysis machine or a continuous renal replacement therapy (CRRT) machine. Treatments are provided for a longer duration than typical intermittent hemodialysis treatments (6-12 h vs. 3-4 h, respectively) but not 24 h per day as is done for continuous renal replacement therapy (CRRT). Usually, PIRRT treatments are provided 4 to 7 times per week. PIRRT is a cost-effective and flexible modality with which to safely provide RRT for critically ill patients. We present a brief review on the use of PIRRT in the ICU with a focus on how we prescribe it in that setting.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Reply to: "Is Prolonged Intermittent Renal Replacement Therapy actually safe for hemodynamically unstable patients?"
    Clark, Edward G.
    Vijayan, Anitha
    CRITICAL CARE, 2023, 27 (01)
  • [22] Pediatric Continuous Renal Replacement Therapy (PCRRT) expert committee recommendation on prescribing prolonged intermittent renal replacement therapy (PIRRT) in critically ill children
    Sethi, Sidharth Kumar
    Mittal, Aliza
    Nair, Nikhil
    Bagga, Arvind
    Iyenger, Arpana
    Ali, Uma
    Sinha, Rajiv
    Agarwal, Indira
    de Sousa Tavares, Marcelo
    Abeyagunawardena, Asiri
    Hanif, Mohammed
    Shreshtha, Devender
    Moorani, Khemchand
    Asim, Sadaf
    Kher, Vijay
    Alhasan, Khalid
    Mourani, Chebl
    Al Riyami, Mohammed
    Bunchman, Timothy E.
    McCulloch, Mignon
    Raina, Rupesh
    HEMODIALYSIS INTERNATIONAL, 2020, 24 (02) : 237 - 251
  • [23] Hemodynamic Stability During Prolonged Intermittent Renal Replacement Therapy-Time to Chill Out*
    Finkel, Kevin W.
    CRITICAL CARE MEDICINE, 2019, 47 (02) : 302 - 303
  • [24] Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians
    Bellomo, R. (rinaldo.bellomo@austin.org.au), 1600, Wichtig Editore s.r.l. (27):
  • [25] Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy
    Economou, Caleb J. P.
    Kielstein, Jan T.
    Czock, David
    Xie, Jiao
    Field, Jonathan
    Richards, Brent
    Tallott, Mandy
    Visser, Adam
    Koenig, Christina
    Hafer, Carsten
    Schmidt, Julius J.
    Lipman, Jeffrey
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 151 - 157
  • [26] Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians
    Naka, T
    Baldwin, I
    Bellomo, R
    Fealy, N
    Wan, L
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 380 - 387
  • [27] Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipient
    Whitmore, Timothy J.
    Cheng, Vesa
    Rawlins, Matthew D.
    Morgan, David
    Chang, Tim
    O'Halloran, Sean
    Dyer, John R.
    Boan, Peter
    Roberts, Jason A.
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (02)
  • [28] Hormone replacement therapy and malignant melanoma: to prescribe or not to prescribe?
    Durvasula, R
    Ahmed, SM
    Vashisht, A
    Studd, JWW
    CLIMACTERIC, 2002, 5 (02) : 197 - 200
  • [29] Pharmacokinetics of flucloxacillin during prolonged intermittent renal replacement therapy in a 76-year-old man
    Fox, Emma
    Cheng, Vesa
    Rawlins, Matthew
    Dyer, John
    De Keulenaer, Bart
    Page, Michael M.
    Hoad, Kirsten
    Roberts, Jason
    JOURNAL OF CHEMOTHERAPY, 2019, 31 (7-8) : 419 - 423
  • [30] Pharmacokinetics of Metronidazole During Prolonged Intermittent Kidney Replacement Therapy
    Xu, Jessica H.
    Cheng, Vesa
    Rawlins, Matthew
    Morgan, David
    Won, Hayoung
    Wu, Xiaolin
    Dyer, John
    Roberts, Jason A.
    HEMODIALYSIS INTERNATIONAL, 2025,